References
- Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, trends among US adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-8
- USRDS. Chapter 2 Incidence & Prevalence. ESRD, 2007:231-40. Available at: http://www.usrds.org/2009/pdf/V2_02_INC_PREV_09.PDF [Last accessed: 5 May 2010]
- Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-15
- Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Int Med 2004;164:659-63
- Smith DH, Gullion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004;15:1300-6
- Coladonato JA, Ritz E. Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patients. Adv Ren Replace Ther 2002;9:193-9
- Hutchison AJ. Predialysis management of a divalent ion metabolism. Kidney Int Suppl 1999;73:S82-4
- Mix TC, St Peter WL, Ebben J, et al. Hospitalization during advancing chronic kidney disease. Am J Kidney Dis 2003;42:972-81
- Haroun MK, Jaar BG, Hoffman SC, et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003;14:2934-41
- U.S Renal Data System. USRDS 2004 annual data report: atlas of end-stage renal disease in the United States. 2004. Available at http://http://www.usrds.org/atlas04.aspx [Last accessed 5 May 2010]
- K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-201
- Smith DH, Johnson ES, Thorp ML, et al. Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes. J Bone Miner Metab 2009;27:287-94
- Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Intl 2008;73:1296-302
- Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
- Levey AS, Bosch JP, Lewis JB, Greene T, Rogerns N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-70
- Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins, 2008
- London R, Solis A, Goldberg GA, et al. Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population. J Manag Care Pharm 2003;9:248-55
- Winkelmayer W, Levin R, Avorn J. The nephrologist’s role in the management of calcium–phosphorus metabolism in patients with chronic kidney disease. Kidney Int 2006;63:1836-42
- Schumock GT, Andress D, Marx S, et al. Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients. Curr Med Res Opin 2008;24:3037-48